Predictive value of increased plasma levels of fibronectin in gestational hypertension

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1989-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0020-7292(90)90957-MPMID 2504045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• Low-dose aspirin in prevention of toxaemia of pregnancy. Does it have a place?

  1988cited by this paper
• Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.

  1987cited by this paper
• Role of von Willebrand Factor in the Vessel Wall

  1987cited by this paper
• Preeclampsia, delivery, and the hemostatic system.

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

  1987cited by this paper
• Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis

  1987cited by this paper
• Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic.

  1986cited by this paper
• Plasma Fibronectin Enhances Fibrinolytic System In Vitro

  1985cited by this paper
• The effect of antiinflammatory drugs on plasma fibronectin.

  1985cited by this paper
• Human fibronectin metabolism.

  1985cited by this paper
• Low antithrombin III and high plasma fibronectin in pre-eclampsia.

  1985cited by this paper
• Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA

  1985cited by this paper
• The Fast Inhibitor of Tissue Plasminogen Activator in Plasma During Pregnancy

  1984cited by this paper
• Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage.

  1984cited by this paper
• Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia

  1971cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper

• Diagnostic Accuracy of Serum Glycosylated Fibronectin in Prediction of Preeclampsia: A Nested Case–Control Study

  2024cites this paper
• Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications.

  2024cites this paper
• Fibronectin and JMJD6 Signature in Circulating Placental Extracellular Vesicles for the Detection of Preeclampsia

  2023cites this paper
• Comparative evaluation of gestosis score vs uterine artery pulsatility index in predicting gestational hypertension: A study protocol

  2023cites this paper
• Predictive value of the second‐trimester fibronectin concentration for severe preeclampsia: A prospective nested case–control study in China

  2022cites this paper
• The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review.

  2022cites this paper
• Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia

  2019cites this paper
• Diagnosis and Management of Deep Vein Thrombosis and Pulmonary Embolism in Pregnancy

  2016cites this paper
• Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia.

  2015cites this paper
• Prospective evaluation of ultrasound and biochemical‐based multivariable models for the prediction of late pre‐eclampsia

  2011cites this paper
• Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks.

  2010cites this paper
• Serum markers in pre-eclampsia

  2009influential citation
• Soluble Flt‐1 as a diagnostic marker of pre‐eclampsia

  2008cites this paper
• [Plasma fibronectin in pregnancy complicated by diabetes mellitus and preeclampsia].

  2008cites this paper
• Performance of a panel of maternal serum markers in predicting preeclampsia at 11–15 weeks' gestation

  2007cites this paper
• CHAPTER 7 Potential Role of Glucocorticoids in the Pathophysiology of Intrauterine Growth Restriction ( lUGR )

  2007cites this paper
• Prospective evaluation of the risk of pre‐eclampsia using logistic regression analysis

  2007cites this paper
• Normotensive and Preeclamptic Pregnant Women During the Anteparturn and Postpartum Periods

  2007cites this paper
• Third Trimester Maternal Plasma Total Fibronectin Levels in Pregnancy-Induced Hypertension: Results of a Tertiary Center

  2006cites this paper
• Potential Role of Glucocorticoids in the Pathophysiology of Intrauterine Growth Restriction (IUGR)

  2006cites this paper
• Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls

  2006cites this paper
• Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study

  2003cites this paper
• Prenatal screening, epidemiology, diagnosis, and management of preeclampsia.

  2003cites this paper
• Effect of ASA on The Risk of Gestational Hypertension or IUGR and Prostanoid Synthesis in Pregnant Women Screened by Doppler Ultrasound

  2003influential citation
• Haemostatic changes in pregnancy.

  2003cites this paper
• Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia.

  2002cites this paper
• Treatment with AT III Concentrate in Pre-Eclampsia

  2002cites this paper
• Früherkennung der Präeklampsie

  2002cites this paper
• Increased plasma fibronectin levels in patients with acute myocardial infarction complicated with left ventricular thrombus.

  2002cites this paper
• Fibronectin is a Marker for Organ Involvement and may Reflect the Severity of Preeclampsia

  2001cites this paper
• The Clinical Value of Microtransferrinuria and Microalbuminuria in the Prediction of Pre-eclampsia

  2001cites this paper
• Plasma fibronectin levels in ischemic heart disease.

  2001cites this paper
• Pathophysiology of preeclampsia and the role of serotonin.

  2001cites this paper
• Fibronectin is a marker for organ involvement and may reflect the severity of preeclampsia.

  2001cites this paper
• The Inhibitors of the Fibrinolytic System

  2001cites this paper
• Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?

  2000cites this paper
• Levels of stable metabolites of prostacyclin and thromboxane A2 and their ratio in normotensive and preeclamptic pregnant women during the antepartum and postpartum periods.

  2000cites this paper
• Plasma endothelin‐1 and mean arterial pressure in the prediction of pre‐eclampsia

  2000cites this paper
• Surgery for urinary incontinence.

  2000cites this paper
• Cytotoxic effects of tumour necrosis factor (TNF)-alpha and interferon-gamma on cultured human trophoblast are modulated by fibronectin.

  2000cites this paper
• The uteroplacental circulation in hypertensive disorders of pregnancy; Doppler ultrasound and histopathological studies

  2000cites this paper
• Predictive markers of pre‐eclampsia in hypertensive disorders of pregnancy

  1999cites this paper
• Calcium Dobesilate Lowers the Blood Pressure in Mild to Moderate Midtrimester Hypertension

  1999cites this paper
• Prediction and prevention of pregnancy-induced hypertensive disorders.

  1999cites this paper
• Pregnancy‐induced hypertension and insulin resistance, evidence for a connection

  1999cites this paper
• Serial plasma fibronectin levels in pre‐eclamptic and normotensive women

  1999cites this paper
• Total Fibronectin in Maternal Plasma as a Predictor for Preeclampsia

  1999cites this paper
• Decidual and Vascular Pathophysiology in Pregnancy Compromise

  1999cites this paper
• [Risk factors in pre-eclampsia].

  1999cites this paper
• Pathogenesis of preeclampsia: a comprehensive model.

  1998cites this paper
• The prediction of preeclampsia: reassessment of clinical value of increased plasma levels of fibronectin.

  1998cites this paper
• Plasma fibronectin levels and age-corrected birth weight in hypertensive-normotensive mothers and their newborns.

  1998cites this paper
• Abnormal Expression of Type 1 Plasminogen Activator Inhibitor and Tissue Factor in Severe Preeclampsia

  1998cites this paper
• Fetal plasma levels of circulating endothelial cell adhesion molecules in normal and preeclamptic pregnancies.

  1998cites this paper
• [Prediction of preeclampsia:new hypotheses, new approaches].

  1998cites this paper
• Total Plasma Fibronectin as a Marker of Pregnancy‐Induced Hypertensive Disorders: A Longitudinal Study

  1998cites this paper
• Placental Cytokines and the Pathogenesis of Preeclampsia

  1997cites this paper
• Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia.

  1997cites this paper
• Increased t-PA and PAI-1 expression of cultured endothelial cells after stimulation with sera from women with preeclampsia

  1997cites this paper
• Biochemical prediction of pre-eclampsia.

  1997cites this paper
• Normal Gebelik ve Preeklampside Gama Glutamil Transferaz ve Fibronektin Aktivitesinin Karşılaştırılması

  1997influential citation
• The pathophysiology of pre-eclampsia

  1997cites this paper
• The Imbalance of Plasminogen Activators and Inhibitor in Preeclampsia

  1996cites this paper
• Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives.

  1996cites this paper
• Glycated albumin promotes a generalized vasculopathy in the db/db mouse.

  1996cites this paper
• Thrombomodulin, plasminogen activator inhibitor type 1 (PAI‐1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia

  1996cites this paper
• Values of certain clinical and biochemical tests for prediction of pre-eclampsia.

  1996cites this paper
• Preeklamptik ve Normal Gebelerde Serum Thrombomodulin Düzeyleri

  1996cites this paper
• Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies

  1996cites this paper
• Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation.

  1996cites this paper
• Fibronectin in the plasma during pregnancy and parturition.

  1996cites this paper
• Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy.

  1996cites this paper
• Decreased Expression of PAI-2 mRNA and Protein in Pregnancies Complicated with Intrauterine Fetal Growth Retardation

  1996influential citation
• Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.

  1996cites this paper
• The laboratory evaluation of hypertensive gravidas.

  1995cites this paper
• Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia.

  1995cites this paper
• Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia.

  1995cites this paper
• Syndromes vasculorénaux de la grossesse

  1995cites this paper
• The pharmacological prevention of pre-eclampsia.

  1995cites this paper
• [Rheumatic diseases in pregnancy--problems from the viewpoint of the gynecologist].

  1995cites this paper
• Utility of a Single Plasma Fibronectin Level for the Prediction of Preeclampsia

  1995cites this paper
• 7b The pharmacological prevention of pre-eclampsia

  1995cites this paper
• ESTUDI DE LA REACTIVITAT PLAQUETÀRIA EN LA GESTACIÓ NORMAL I EN ELS TRASTORNS HIPERTENSIUS DE L'EMBARÀS

  1995cites this paper
• Biological and clinical aspects of plasminogen activator inhibitor type 2.

  1995cites this paper
• [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].

  1995cites this paper
• Plasma Levels of von Willebrand Factor and Fibronectin as Markers of Persisting Endothelial Damage in Preeclampsia

  1994cites this paper
• 10 Myeloproliferative and metabolic causes

  1994cites this paper
• Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation.

  1994cites this paper
• The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy

  1994cites this paper
• The Role of Some Clinical and Laboratory Tests in the Prediction of Preeclampsia

  1994cites this paper
• Myeloproliferative and metabolic causes.

  1994cites this paper
• Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies.

  1994cites this paper
• Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.

  1994cites this paper
• Clotting inhibitors and fibronectin as potential markers in preeclampsia

  1994cites this paper
• Noninvasive test of microvascular endothelial function in normal and hypertensive pregnancies

  1993cites this paper
• Changes in platelet reactivity following aspirin treatment for pre‐eclampsia

  1993cites this paper
• Maternaler Fibronektin-Plasmaspiegel bei schwangerschaftsinduzierter Hypertonie, Präeklampsie und Plazentainsuffizienz

  1993cites this paper
• The prediction of pre-eclampsia

  1993cites this paper
• A prospective study of several potential biologic markers for early prediction of the development of preeclampsia.

  1993cites this paper
• Endothelial function in normal and pre-eclamptic pregnancy: a hypothesis.

  1992cites this paper